Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial
暂无分享,去创建一个
H. D. de Koning | R. V. van Klaveren | M. Essink‐bot | G. Borsboom | E. Scholten | K. V. D. van den Bergh | R. J. Klaveren | E. Scholten | H. de Koning | K.A.M. van den Bergh | M.L. Essink-Bot | G.J.J.M. Borsboom | R.J. van Klaveren | K. D. Bergh | H. J. Koning
[1] P. Martikainen,et al. Smoking and SF-36 health functioning. , 2006, Preventive medicine.
[2] H. D. de Koning,et al. Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias? , 2004, Journal of medical screening.
[3] J. Habbema,et al. Risk‐based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch‐Belgian randomised lung cancer multi‐slice CT screening trial (NELSON) , 2007, International journal of cancer.
[4] G. Guyatt,et al. The minimal detectable change cannot reliably replace the minimal important difference. , 2010, Journal of clinical epidemiology.
[5] Harry J de Koning,et al. Management of lung nodules detected by volume CT scanning. , 2009, The New England journal of medicine.
[6] H. D. de Koning,et al. Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON) , 2009, British Journal of Cancer.
[7] E. Gelmann,et al. Quality of life and trial adherence among participants in the prostate, lung, colorectal, and ovarian cancer screening trial. , 2004, Journal of the National Cancer Institute.
[8] J. Ware,et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. , 1998, Journal of clinical epidemiology.
[9] G. Bonsel,et al. Generalizability of valuations on health states collected with the EuroQolc-questionnaire. , 1993, Health economics.
[10] J. Ware,et al. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.
[11] Ruth Etzioni,et al. Trends in Treatment Costs for Localized Prostate Cancer: The Healthy Screenee Effect , 2007, Medical care.
[12] E. Steegers,et al. Validation of the Dutch Short Form of the State Scale of the Spielberger State-Trait Anxiety Inventory: Considerations for Usage in Screening Outcomes , 2003, Public Health Genomics.
[13] G. Norman,et al. Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.
[14] Paul Kind,et al. EQ-5D concepts and methods : a developmental history , 2005 .
[15] D. Xu,et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. , 2006, Lung cancer.
[16] M. Horowitz,et al. Impact of Event Scale: A Measure of Subjective Stress , 1979, Psychosomatic medicine.
[17] J. Weissfeld,et al. Anxiety, Fear of Cancer, and Perceived Risk of Cancer following Lung Cancer Screening , 2008, Medical decision making : an international journal of the Society for Medical Decision Making.
[18] S. Moss,et al. The psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: 6-month follow-up , 2005, British Journal of Cancer.
[19] A. Miller,et al. Health-related quality of life and cost-effectiveness studies in the European randomised study of screening for prostate cancer and the US Prostate, Lung, Colon and Ovary trial. , 2001, European journal of cancer.
[20] Harry J de Koning,et al. Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial) , 2008, Cancer.
[21] R. Järvenpää,et al. Psychological impact of computed tomography screening for lung cancer and occupational pulmonary disease among asbestos-exposed workers , 2009, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.